Cargando…

The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival

The IGROVCDDP cisplatin-resistant ovarian cancer cell line is an unusual model, as it is also cross-resistant to paclitaxel. IGROVCDDP, therefore, models the resistance phenotype of serous ovarian cancer patients who have failed frontline platinum/taxane chemotherapy. IGROVCDDP has also undergone ep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rae, Sophie, Spillane, Cathy, Blackshields, Gordon, Madden, Stephen F., Keenan, Joanne, Stordal, Britta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374625/ https://www.ncbi.nlm.nih.gov/pubmed/35794446 http://dx.doi.org/10.1007/s13577-022-00744-y

Ejemplares similares

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
por: McEvoy, Lynda M., et al.
Publicado: (2015)

The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
por: Sánchez-Tilló, Ester, et al.
Publicado: (2023)

CD10(−)/ALDH(−) cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy
por: Ffrench, Brendan, et al.
Publicado: (2017)

ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC
por: Lazarova, Darina, et al.
Publicado: (2017)

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
por: Chebouti, Issam, et al.
Publicado: (2017)

Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb
por: Egger, Jacklynn V., et al.
Publicado: (2016)

Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
por: Wu, Hua-Tao, et al.
Publicado: (2020)

Zeb2 directs EMT-like processes that underlies the glial response to injury
por: Vivinetto, Ana L., et al.
Publicado: (2021)

OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets
por: Madden, Stephen F, et al.
Publicado: (2014)

Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity
por: Wang, Jueqiong, et al.
Publicado: (2021)

The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer
por: Bates, Mark, et al.
Publicado: (2020)

ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1
por: Liu, D, et al.
Publicado: (2018)

EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
por: Lindner, Pablo, et al.
Publicado: (2020)

Ets family proteins regulate the EMT transcription factors Snail and ZEB in cancer cells
por: Ichikawa, Mai Koizumi, et al.
Publicado: (2022)

Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells
por: Egan, Karl, et al.
Publicado: (2011)

An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines
por: Vencken, Sebastian F, et al.
Publicado: (2014)

Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2
por: Zhang, Fenghua, et al.
Publicado: (2020)

miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
por: Harazono, Yosuke, et al.
Publicado: (2013)

The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
por: Mock, Kerstin, et al.
Publicado: (2015)

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions
por: Vandewalle, Cindy, et al.
Publicado: (2005)

A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
por: Preca, Bogdan-Tiberius, et al.
Publicado: (2017)

Genome‐wide cooperation of EMT transcription factor ZEB1 with YAP and AP‐1 in breast cancer
por: Feldker, Nora, et al.
Publicado: (2020)

The microRNA-708-5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma
por: Feng, Tianyu, et al.
Publicado: (2020)

Dihydroartemisinin inhibits EMT induced by platinum-based drugs via Akt–Snail pathway
por: Qin, Yuan, et al.
Publicado: (2017)

CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1
por: Zhou, Jiayi, et al.
Publicado: (2019)

miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
por: GUO, FEI, et al.
Publicado: (2014)

LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
por: Liang, Haihai, et al.
Publicado: (2018)

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
por: Liang, Haihai, et al.
Publicado: (2021)

Hypoxia Promotes Prostate Cancer Aggressiveness by Upregulating EMT-Activator Zeb1 and SK3 Channel Expression
por: Bery, Fanny, et al.
Publicado: (2020)

Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020)

UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis
por: Shi, Dandan, et al.
Publicado: (2020)

CBX6 Promotes HCC Metastasis Via Transcription Factors Snail/Zeb1-Mediated EMT Mechanism
por: Wang, Jiamu, et al.
Publicado: (2020)

The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells
por: Banerjee, Priyam, et al.
Publicado: (2021)

ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression
por: Shen, Huojian, et al.
Publicado: (2021)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
por: Jernigan, Amelia M., et al.
Publicado: (2013)

miRNA-199b-3p suppresses growth and progression of ovarian cancer via the CHK1/E-cadherin/EMT signaling pathway by targeting ZEB1
por: Wei, Liqun, et al.
Publicado: (2021)

Three Novel De Novo ZEB2 Variants Identified in Three Unrelated Chinese Patients With Mowat-Wilson Syndrome and A Systematic Review
por: Fu, Youqing, et al.
Publicado: (2022)

MiR-132 Suppresses the Migration and Invasion of Lung Cancer Cells via Targeting the EMT Regulator ZEB2
por: You, Jiacong, et al.
Publicado: (2014)

Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer
por: Wang, Tingting, et al.
Publicado: (2017)

An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
por: Li, Ningning, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7tmed2o4hqoiubimi8jrretb6s